Ginsberg, G. M., Somekh, E., & Schlesinger, Y. (2018). Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis. Isr J Health Policy Res.
Style de citation ChicagoGinsberg, Gary M., Eli Somekh, et Yechiel Schlesinger. "Should We Use Palivizumab Immunoprophylaxis for Infants against Respiratory Syncytial Virus? – a Cost-utility Analysis." Isr J Health Policy Res 2018.
Style de citation MLAGinsberg, Gary M., Eli Somekh, et Yechiel Schlesinger. "Should We Use Palivizumab Immunoprophylaxis for Infants against Respiratory Syncytial Virus? – a Cost-utility Analysis." Isr J Health Policy Res 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.